{"id":132521,"date":"2021-12-16T13:22:55","date_gmt":"2021-12-16T21:22:55","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/12\/roche-genentech-recursion-launch-up-to-12b-ai-drug-discovery-effort"},"modified":"2021-12-16T13:22:55","modified_gmt":"2021-12-16T21:22:55","slug":"roche-genentech-recursion-launch-up-to-12b-ai-drug-discovery-effort","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/12\/roche-genentech-recursion-launch-up-to-12b-ai-drug-discovery-effort","title":{"rendered":"Roche, Genentech, Recursion Launch Up-to-$12B AI Drug Discovery Effort"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/roche-genentech-recursion-launch-up-to-12b-ai-drug-discovery-effort.jpg\"><\/a><\/p>\n<p>Roche and its Genentech subsidiary have committed up to $12 billion to Recursion in return for using its Recursion Operating System (OS) to advance therapies in 40 programs that include \u201ckey areas\u201d of neuroscience and an undisclosed oncology indication.<\/p>\n<p>Recursion OS applies machine learning and high-content screening methods in what the companies said would be a \u201ctransformational\u201d model for tech-enabled target and drug discovery.<\/p>\n<p>The integrated, multi-faceted OS is designed to generate, analyze and glean insights from large-scale proprietary biological and chemical datasets\u2014in this case, extensive single-cell perturbation screening data from Roche and Genentech\u2014by integrating wet-lab and dry-lab biology at scale to phenomically capture chemical and genetic alterations in neuroscience-related cell types and select cancer cell lines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Roche and its Genentech subsidiary have committed up to $12 billion to Recursion in return for using its Recursion Operating System (OS) to advance therapies in 40 programs that include \u201ckey areas\u201d of neuroscience and an undisclosed oncology indication. Recursion OS applies machine learning and high-content screening methods in what the companies said would be [\u2026]<\/p>\n","protected":false},"author":556,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,412,47,6],"tags":[],"class_list":["post-132521","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-genetics","category-neuroscience","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/132521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=132521"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/132521\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=132521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=132521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=132521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}